Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Purdue To Market Palladone With Fewer Reps After Halving Sales Force

Executive Summary

Purdue will promote Palladone (hydromorphone extended-release) with significantly fewer reps after laying off half its sales force

You may also be interested in...



Purdue Withdraws Palladone; FDA Evaluating Other Extended-Release Opiates

FDA is evaluating the potential for an alcohol interaction with other sustained-release opiates following the withdrawal of Purdue Pharma's Palladone due to the potential for serious alcohol-related adverse events

Purdue Withdraws Palladone; FDA Evaluating Other Extended-Release Opiates

FDA is evaluating the potential for an alcohol interaction with other sustained-release opiates following the withdrawal of Purdue Pharma's Palladone due to the potential for serious alcohol-related adverse events

“Authorized” Generic Opponents Turn To State Laws After Federal Court Loss

Generic companies are pursuing alternative litigation routes in their efforts to block "authorized" generics following a Washington, D.C. appeals court decision upholding FDA's current policy on the products

Related Content

Topics

UsernamePublicRestriction

Register

PS046058

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel